At Day 3 (N = 469 (%)) | n (%) |
---|---|
Digestive adverse reactions | 115 (24.5) |
Nausea or vomiting | 82 (17.5) |
Diarrhoea | 16 (3.4) |
Abdominal pain | 10 (2.1) |
Others | 7 (1.5) |
Cutaneous | 10 (2.1) |
Headache | 18 (7.4) |
Myalgia | 3 (0.6) |
Arthralgia | 3 (0.6) |
Anxiety | 1 (0.2) |
Total ADR° at Day 3 | 150 (32.0) |
At Day 7 (N = 364 (%))* | |
Digestive adverse reactions | 11 (3.0) |
Nausea | 3 (0.8) |
Diarrhoea | 4 (1.1) |
Others | 4 (1.1) |
Cutaneous | 7 (1.9) |
Headache | 7 (1.9) |
Total ADR° at Day 7 | 25 (6.9) |
At Day 30 (N = 265 (%))* | |
Digestive adverse reactions | 1 (0.4) |
Nausea | 0 |
Diarrhoea | 1 (0.4) |
Cutaneous | 1 (0.4) |
Headache | 0 |
Total ADR* at Day 30° | 2(0.8) |